Logo image of LEN

LENNAR CORP-A (LEN) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:LEN - US5260571048 - Common Stock

118.59 USD
-3.66 (-2.99%)
Last: 1/16/2026, 8:04:00 PM
118.59 USD
0 (0%)
After Hours: 1/16/2026, 8:04:00 PM
Fundamental Rating

5

LEN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 60 industry peers in the Household Durables industry. Both the profitability and the financial health of LEN get a neutral evaluation. Nothing too spectacular is happening here. While showing a medium growth rate, LEN is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year LEN was profitable.
  • LEN had a negative operating cash flow in the past year.
  • Each year in the past 5 years LEN has been profitable.
  • LEN had a positive operating cash flow in 4 of the past 5 years.
LEN Yearly Net Income VS EBIT VS OCF VS FCFLEN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

1.2 Ratios

  • LEN has a Return On Assets of 7.62%. This is in the better half of the industry: LEN outperforms 70.00% of its industry peers.
  • The Return On Equity of LEN (11.77%) is comparable to the rest of the industry.
  • LEN's Return On Invested Capital of 8.53% is fine compared to the rest of the industry. LEN outperforms 61.67% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for LEN is in line with the industry average of 9.71%.
Industry RankSector Rank
ROA 7.62%
ROE 11.77%
ROIC 8.53%
ROA(3y)10.3%
ROA(5y)11.22%
ROE(3y)15.58%
ROE(5y)17.34%
ROIC(3y)10.18%
ROIC(5y)11.88%
LEN Yearly ROA, ROE, ROICLEN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • LEN's Profit Margin of 7.64% is fine compared to the rest of the industry. LEN outperforms 65.00% of its industry peers.
  • In the last couple of years the Profit Margin of LEN has remained more or less at the same level.
  • LEN has a Operating Margin of 10.61%. This is in the better half of the industry: LEN outperforms 68.33% of its industry peers.
  • In the last couple of years the Operating Margin of LEN has declined.
  • LEN has a Gross Margin of 12.38%. This is amonst the worse of the industry: LEN underperforms 93.33% of its industry peers.
  • LEN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 10.61%
PM (TTM) 7.64%
GM 12.38%
OM growth 3Y-22.67%
OM growth 5Y-8.83%
PM growth 3Y-4.93%
PM growth 5Y1.45%
GM growth 3Y-7.29%
GM growth 5Y0.84%
LEN Yearly Profit, Operating, Gross MarginsLEN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

6

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so LEN is still creating some value.
  • LEN has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for LEN has been reduced compared to 5 years ago.
  • LEN has a worse debt/assets ratio than last year.
LEN Yearly Shares OutstandingLEN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
LEN Yearly Total Debt VS Total AssetsLEN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

2.2 Solvency

  • An Altman-Z score of 4.23 indicates that LEN is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of LEN (4.23) is better than 71.67% of its industry peers.
  • A Debt/Equity ratio of 0.24 indicates that LEN is not too dependend on debt financing.
  • The Debt to Equity ratio of LEN (0.24) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Altman-Z 4.23
ROIC/WACC0.96
WACC8.91%
LEN Yearly LT Debt VS Equity VS FCFLEN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

2.3 Liquidity

  • LEN has a Current Ratio of 9.39. This indicates that LEN is financially healthy and has no problem in meeting its short term obligations.
  • LEN's Current ratio of 9.39 is amongst the best of the industry. LEN outperforms 91.67% of its industry peers.
  • A Quick Ratio of 1.76 indicates that LEN should not have too much problems paying its short term obligations.
  • LEN has a better Quick ratio (1.76) than 76.67% of its industry peers.
Industry RankSector Rank
Current Ratio 9.39
Quick Ratio 1.76
LEN Yearly Current Assets VS Current LiabilitesLEN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

5

3. Growth

3.1 Past

  • The earnings per share for LEN have decreased strongly by -44.28% in the last year.
  • LEN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 0.33% yearly.
  • Looking at the last year, LEN shows a decrease in Revenue. The Revenue has decreased by -3.54% in the last year.
  • LEN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.74% yearly.
EPS 1Y (TTM)-44.28%
EPS 3Y-20.53%
EPS 5Y0.33%
EPS Q2Q%-52.46%
Revenue 1Y (TTM)-3.54%
Revenue growth 3Y0.51%
Revenue growth 5Y8.74%
Sales Q2Q%-5.82%

3.2 Future

  • Based on estimates for the next years, LEN will show a very strong growth in Earnings Per Share. The EPS will grow by 25.99% on average per year.
  • The Revenue is expected to grow by 7.26% on average over the next years.
EPS Next Y-3.89%
EPS Next 2Y9.36%
EPS Next 3Y16.99%
EPS Next 5Y25.99%
Revenue Next Year-1.73%
Revenue Next 2Y1.62%
Revenue Next 3Y3.9%
Revenue Next 5Y7.26%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
LEN Yearly Revenue VS EstimatesLEN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B
LEN Yearly EPS VS EstimatesLEN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15 20 25

3

4. Valuation

4.1 Price/Earnings Ratio

  • LEN is valuated correctly with a Price/Earnings ratio of 14.84.
  • Compared to the rest of the industry, the Price/Earnings ratio of LEN is on the same level as its industry peers.
  • The average S&P500 Price/Earnings ratio is at 27.38. LEN is valued slightly cheaper when compared to this.
  • LEN is valuated correctly with a Price/Forward Earnings ratio of 15.44.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of LEN is on the same level as its industry peers.
  • LEN is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 24.29, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 14.84
Fwd PE 15.44
LEN Price Earnings VS Forward Price EarningsLEN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as LEN.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.89
LEN Per share dataLEN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80 100

4.3 Compensation for Growth

  • LEN's earnings are expected to grow with 16.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)45.17
EPS Next 2Y9.36%
EPS Next 3Y16.99%

6

5. Dividend

5.1 Amount

  • LEN has a Yearly Dividend Yield of 1.64%.
  • LEN's Dividend Yield is a higher than the industry average which is at 1.16.
  • LEN's Dividend Yield is comparable with the S&P500 average which is at 1.85.
Industry RankSector Rank
Dividend Yield 1.64%

5.2 History

  • On average, the dividend of LEN grows each year by 65.54%, which is quite nice.
  • LEN has paid a dividend for at least 10 years, which is a reliable track record.
  • LEN has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)65.54%
Div Incr Years1
Div Non Decr Years15
LEN Yearly Dividends per shareLEN Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

  • 19.91% of the earnings are spent on dividend by LEN. This is a low number and sustainable payout ratio.
  • LEN's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP19.91%
EPS Next 2Y9.36%
EPS Next 3Y16.99%
LEN Yearly Income VS Free CF VS DividendLEN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B
LEN Dividend Payout.LEN Dividend Payout, showing the Payout Ratio.LEN Dividend Payout.PayoutRetained Earnings

LENNAR CORP-A

NYSE:LEN (1/16/2026, 8:04:00 PM)

After market: 118.59 0 (0%)

118.59

-3.66 (-2.99%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)12-16
Earnings (Next)03-18
Inst Owners96.66%
Inst Owner Change0.16%
Ins Owners1.22%
Ins Owner Change0.31%
Market Cap30.24B
Revenue(TTM)34.19B
Net Income(TTM)2.66B
Analysts54.81
Price Target112.51 (-5.13%)
Short Float %5.42%
Short Ratio1.77
Dividend
Industry RankSector Rank
Dividend Yield 1.64%
Yearly Dividend2
Dividend Growth(5Y)65.54%
DP19.91%
Div Incr Years1
Div Non Decr Years15
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.1%
Min EPS beat(2)-7.71%
Max EPS beat(2)7.91%
EPS beat(4)2
Avg EPS beat(4)2.19%
Min EPS beat(4)-7.71%
Max EPS beat(4)11.86%
EPS beat(8)6
Avg EPS beat(8)6.21%
EPS beat(12)9
Avg EPS beat(12)9.23%
EPS beat(16)11
Avg EPS beat(16)5.39%
Revenue beat(2)1
Avg Revenue beat(2)-0.69%
Min Revenue beat(2)-3.05%
Max Revenue beat(2)1.66%
Revenue beat(4)2
Avg Revenue beat(4)-0.51%
Min Revenue beat(4)-3.05%
Max Revenue beat(4)1.66%
Revenue beat(8)5
Avg Revenue beat(8)0.71%
Revenue beat(12)8
Avg Revenue beat(12)2.24%
Revenue beat(16)11
Avg Revenue beat(16)1.82%
PT rev (1m)-13.18%
PT rev (3m)-16.5%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.68%
EPS NY rev (1m)-14.56%
EPS NY rev (3m)-19.78%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.5%
Revenue NY rev (1m)-4.77%
Revenue NY rev (3m)-5.04%
Valuation
Industry RankSector Rank
PE 14.84
Fwd PE 15.44
P/S 0.87
P/FCF N/A
P/OCF N/A
P/B 1.34
P/tB 1.6
EV/EBITDA 8.89
EPS(TTM)7.99
EY6.74%
EPS(NY)7.68
Fwd EY6.48%
FCF(TTM)-2.8
FCFYN/A
OCF(TTM)-2.23
OCFYN/A
SpS136.33
BVpS88.5
TBVpS74.26
PEG (NY)N/A
PEG (5Y)45.17
Graham Number126.14
Profitability
Industry RankSector Rank
ROA 7.62%
ROE 11.77%
ROCE 11.15%
ROIC 8.53%
ROICexc 8.99%
ROICexgc 14.18%
OM 10.61%
PM (TTM) 7.64%
GM 12.38%
FCFM N/A
ROA(3y)10.3%
ROA(5y)11.22%
ROE(3y)15.58%
ROE(5y)17.34%
ROIC(3y)10.18%
ROIC(5y)11.88%
ROICexc(3y)11.92%
ROICexc(5y)13.71%
ROICexgc(3y)18.83%
ROICexgc(5y)18.96%
ROCE(3y)13.3%
ROCE(5y)15.53%
ROICexgc growth 3Y-1.59%
ROICexgc growth 5Y11.09%
ROICexc growth 3Y-22.05%
ROICexc growth 5Y-3.19%
OM growth 3Y-22.67%
OM growth 5Y-8.83%
PM growth 3Y-4.93%
PM growth 5Y1.45%
GM growth 3Y-7.29%
GM growth 5Y0.84%
F-Score4
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Debt/EBITDA 1.41
Cap/Depr 111.6%
Cap/Sales 0.42%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 9.39
Quick Ratio 1.76
Altman-Z 4.23
F-Score4
WACC8.91%
ROIC/WACC0.96
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-44.28%
EPS 3Y-20.53%
EPS 5Y0.33%
EPS Q2Q%-52.46%
EPS Next Y-3.89%
EPS Next 2Y9.36%
EPS Next 3Y16.99%
EPS Next 5Y25.99%
Revenue 1Y (TTM)-3.54%
Revenue growth 3Y0.51%
Revenue growth 5Y8.74%
Sales Q2Q%-5.82%
Revenue Next Year-1.73%
Revenue Next 2Y1.62%
Revenue Next 3Y3.9%
Revenue Next 5Y7.26%
EBIT growth 1Y-34.32%
EBIT growth 3Y-22.28%
EBIT growth 5Y-0.86%
EBIT Next Year-17.91%
EBIT Next 3Y12.63%
EBIT Next 5Y18.06%
FCF growth 1Y-118.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-114.14%
OCF growth 3YN/A
OCF growth 5YN/A

LENNAR CORP-A / LEN FAQ

What is the ChartMill fundamental rating of LENNAR CORP-A (LEN) stock?

ChartMill assigns a fundamental rating of 5 / 10 to LEN.


What is the valuation status for LEN stock?

ChartMill assigns a valuation rating of 3 / 10 to LENNAR CORP-A (LEN). This can be considered as Overvalued.


How profitable is LENNAR CORP-A (LEN) stock?

LENNAR CORP-A (LEN) has a profitability rating of 5 / 10.


How financially healthy is LENNAR CORP-A?

The financial health rating of LENNAR CORP-A (LEN) is 6 / 10.


Is the dividend of LENNAR CORP-A sustainable?

The dividend rating of LENNAR CORP-A (LEN) is 6 / 10 and the dividend payout ratio is 19.91%.